Oral Lichenoid Lesions Due to Nivolumab: A Case Report and Review of the Literature-Reference-Cited by-同舟云学术

Oral Lichenoid Lesions Due to Nivolumab: A Case Report and Review of the Literature

Published:2020 Issue:1 Volume:26 Page:56-62
ISSN:2186-6147
Container-title:Journal of Japanese Society of Oral Medicine
language:en
Short-container-title:J. Jpn. Oral Medicine

Author:

NAKAMURA Tomohisa¹,JINBU Yoshinori²³,SHIBUYA Yasuyuki¹,DEMITSU Toshio⁴,MORI Yoshiyuki²

Affiliation:

1. Department of Oral and Maxillofacial Surgery, Nagoya City University Graduate School of Medical Sciences

2. Department of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University

3. Department of Dentistry, Oral and Maxillofacial Surgery, International University of Health and Welfare

4. Department of Dermatology, Jichi Medical School Saitama Medical Center

Publisher

Japanese Society of Oral Medicine

Link

https://www.jstage.jst.go.jp/article/jjsom/26/1/26_56/_pdf

Reference29 articles.

1. 1）Hwang SJ, Carlos G, Wakade, et al: Cutaneous adverse events （AEs） of anti-programmed cell death （PD）-1 therapy in patients with metastatic melanoma: A single-institution cohort. J Am Acad Dermatol 74：455-461, 2016.

2. 2）Lacouture M and Sibaud V: Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails. Am J Clin Dermatol 19：31-39, 2018.

3. 3）Michot JM, Bigenwald C, Champiat S, et al: Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54：139-148, 2016.

4. 4）Brahmer JR, Lacchetti C, Schneider BJ, et al: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 36：1714-1768, 2018.

5. 5）Kaunitz GJ, Loss M, Rizvi H, et al: Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern. Am J Surg Pathol 41：1381-1389, 2017.